Literature DB >> 23247489

A new spectrum of skin toxic effects associated with the multikinase inhibitor vandetanib.

Damien Giacchero, Constanza Ramacciotti, Jean Philippe Arnault, Maryse Brassard, Eric Baudin, Laurent Maksimovic, Christine Mateus, Gorana Tomasic, Janine Wechsler, Martin Schlumberger, Caroline Robert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23247489     DOI： 10.1001/2013.jamadermatol.192

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  13 in total

1.  Treating medullary thyroid cancer in the age of targeted therapy.

Authors:  Maria E Cabanillas; Mimi I Hu; Camilo Jimenez; Elizabeth G Grubbs; Gilbert J Cote
Journal:  Int J Endocr Oncol       Date:  2014

2.  The Treatment of Advanced Thyroid Cancer in the Age of Novel Targeted Therapies.

Authors:  Roy Lirov; Francis P Worden; Mark S Cohen
Journal:  Drugs       Date:  2017-05       Impact factor: 9.546

Review 3.  Overview and management of dermatologic events associated with targeted therapies for medullary thyroid cancer.

Authors:  Mario E Lacouture; Kathryn Ciccolini; Richard T Kloos; Mark Agulnik
Journal:  Thyroid       Date:  2014-07-15       Impact factor: 6.568

4.  Development of Photoonycholysis with Vandetanib Therapy.

Authors:  Miruna Negulescu; Slimane Zerdoud; Serge Boulinguez; Emilie Tournier; Jean-Pierre Delord; Robert Baran; Vincent Sibaud
Journal:  Skin Appendage Disord       Date:  2016-11-03

Review 5.  Selective use of vandetanib in the treatment of thyroid cancer.

Authors:  Poupak Fallahi; Flavia Di Bari; Silvia Martina Ferrari; Roberto Spisni; Gabriele Materazzi; Paolo Miccoli; Salvatore Benvenga; Alessandro Antonelli
Journal:  Drug Des Devel Ther       Date:  2015-07-03       Impact factor: 4.162

6.  Photoallergic reaction in a patient receiving vandetanib for metastatic follicular thyroid carcinoma: a case report.

Authors:  Jennifer Goldstein; Anisha B Patel; Jonathan L Curry; Vivek Subbiah; Sarina Piha-Paul
Journal:  BMC Dermatol       Date:  2015-02-13

7.  A rare case of late-onset lichenoid photodermatitis after vandetanib therapy.

Authors:  James Bota; Valerie Harvey; Cynthia Ferguson; Antoinette Hood
Journal:  JAAD Case Rep       Date:  2015-05-25

8.  Dermoscopic findings of perifollicular pigmentation associated with vandetanib.

Authors:  Jade Cury-Martins; Jose Antonio Sanches
Journal:  Dermatol Pract Concept       Date:  2018-10-31

Review 9.  Vandetanib in advanced medullary thyroid cancer: review of adverse event management strategies.

Authors:  Enrique Grande; Michael C Kreissl; Sebastiano Filetti; Kate Newbold; Walter Reinisch; Caroline Robert; Martin Schlumberger; Lærke K Tolstrup; Jose L Zamorano; Jaume Capdevila
Journal:  Adv Ther       Date:  2013-11-19       Impact factor: 3.845

10.  A rare cutaneous phototoxic rash after vandetanib therapy in a patient with thyroid cancer: A case report.

Authors:  Yue Yin; Xin Ye Qiu; Yan Hua Zhang; Bin Zhang
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.